Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5178806
Max Phase: Preclinical
Molecular Formula: C30H38ClN3O4S
Molecular Weight: 572.17
Associated Items:
ID: ALA5178806
Max Phase: Preclinical
Molecular Formula: C30H38ClN3O4S
Molecular Weight: 572.17
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nnc(-c3cccc(Cl)c3)[nH]2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C30H38ClN3O4S/c1-6-28(4)15-22(29(5)17(2)10-12-30(18(3)25(28)37)13-11-21(35)24(29)30)38-23(36)16-39-27-32-26(33-34-27)19-8-7-9-20(31)14-19/h6-9,14,17-18,22,24-25,37H,1,10-13,15-16H2,2-5H3,(H,32,33,34)/t17-,18+,22-,24+,25+,28-,29+,30+/m1/s1
Standard InChI Key: OCHFMUPZLPENFR-POGRXDPOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 572.17 | Molecular Weight (Monoisotopic): 571.2272 | AlogP: 6.12 | #Rotatable Bonds: 6 |
Polar Surface Area: 105.17 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.26 | CX Basic pKa: 1.64 | CX LogP: 5.64 | CX LogD: 5.59 |
Aromatic Rings: 2 | Heavy Atoms: 39 | QED Weighted: 0.24 | Np Likeness Score: 0.74 |
1. Wang X, Wang R, Zhang ZS, Zhang GY, Jin Z, Shen R, Du D, Tang YZ.. (2022) Semisynthetic pleuromutilin antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus by targeting 50S ribosomal subunit., 237 [PMID:35430480] [10.1016/j.ejmech.2022.114341] |
Source(1):